Eight distinct CAF markers (αSMA, collagen-1, caveolin-1, CD140β, FAP, integrin α11, FSP-1 and CD90) were optimized during this study and validated on five HNSCC tumor samples. This evidence concerns the gene CAV1 and head and neck squamous cell carcinoma.